FDA Slaps Botox, Similar Toxins With MedWatch Alert

Law360, New York (April 30, 2009, 12:00 AM EDT) -- More than a year after initiating a safety review, the U.S. Food and Drug Administration has ordered its strictest safety warning to be attached to Allergan Inc.'s Botox and other similar products amid fears that the potentially deadly toxins could spread beyond the point of injection.

The FDA issued a MedWatch alert Thursday, indicating that it will require manufacturers of licensed botulinum toxin products to add a black box label to their products that warns doctors and patients of possible side effects.

The agency is also...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.